Subscribe to our Newsletters !!

    Kumar Jeetendra

    New mass spectrometry-based test recognizes coronavirus in wash arrangements of patients

    Pharmacists in Martin Luther University Halle-Wittenberg (MLU) have succeeded in detecting small amounts of coronavirus SARS-CoV-2 utilizing mass spectrometry. Because of their own investigation , they used naturopathic remedies of COVID-19 patients. The publication method might supplement conventional tests. It’s undergoing developments and could be available as standard diagnostic tool for COVID-19 in the future.

    Oxford Covid antibody beginning phase preliminary shows promise

    London, A Covid-19 vaccine manufactured by researchers at Oxford University generated an immune response from the disease in Phase-1 trial,” The Telegraph reported even as official book of those answers are awaited. Even the Oxford vaccine candidate is believed to be contributing the race among over 100 to obtain a successful protection against the disorder.

    Rising hydrogel material could improve oral drug delivery

    A emerging hydrogel material with the capability to degrade and reform from the gastro intestinal tract can help scientists develop effective procedures for oral drug delivery. The team’s microrheology research is included within a guide and interior cover example from the present dilemma of Soft Issue . To describe the material and supply insight to

    Execution of Covid-19 Antibody Tests Ranked

    An peer-reviewed study by researchers in NSF International and also Novateur Ventures, Vancouver, British Columbia, Canada, found significant variability within the accuracy of now available covid-19 antibody tests.1 From the absence of experiments and effective therapeutics such as SARS-CoV-2 and also the associated covid-19 disorder, dependable antibody testing is sometimes a key section of general

    HPV Test Misses Twice the same number of Women Who Develop Cervical Cancer as Cotesting

    A Health Trends research from researchers in Quest Diagnostics, Secaucus, NJ, and the University of Pittsburgh Medical Center demonstrates the human papillomavirus (HPV) screening evaluation is less likely to find cervical cancer and precancer compared to cotesting, a procedure that combines HPV and Pap (Papanicolaou evaluation by liquid-based cytology) testing with the exact same specimen1

    Bharat Biotech begins human preliminaries of Covaxin

    Bharat Biotech has initiated human clinical trials for Covaxin, a vaccine candidate for COVID-19, across the nation with 375 volunteers, amid the surging numbers of coronavirus cases. India’s COVID-19 caseload jumped to 10,38,716 with 34,884 people testing positive for coronavirus in the last 24 hours, based on information published by the Union Health Ministry on

    China fights new flare-up in far west Xinjiang

    The number of confirmed cases in a new COVID-19 epidemic in China’s far west has climbed to 17. The National Health Commission said Saturday that 16 more cases had been identified in the previous 24 hours in the Xinjiang region, in addition to a very first case. The outbreak at the city of Urumqi is

    Study uncovers antiviral impacts of curcumin

    Curcumin, a natural compound found in the spice turmeric, could help remove specific viruses, studies have found. A study published in the Journal of General Virology revealed that curcumin can prevent Transmissible gastroenteritis virus (TGEV) – an alpha-group coronavirus that infects pigs – from infecting cells. At higher doses, the compound was also found to

    Zydus Cadila gets final approval from USFDA to Advertise generic tension headache Pills

    Medication firm Zydus Cadila on Saturday said it has received final approval from the US health regulator to market generic Butalbital, Acetaminophen and Caffeine combination pills to cure symptoms of tension headaches. The company has obtained final approval from that the United States Food and Drug Administration (USFDA) to market Butalbital, Acetaminophen and Caffeine tablets

    Britain signs manages Pfizer, BioNTech, Valneva for COVID-19 antibodies

    Britain has signed deals to procure 90 million doses of 2 possible COVID-19 vaccines in the Pfizer Inc and BioNTech alliance and French group Valneva, the company ministry said on Monday. Britain had procured 30 million doses of the experimental BioNTech/Pfizer vaccine, and a deal in principle for 60 million doses of this Valneva vaccine,